Also, there was a significant difference (p = 0.000) between ILD-SSc patients with positive antibodies especially ACA (34.6%) and mixed antibodies (ANA &ACA &/or Anti SCL-70 about 30.8%) while ANA alone was positive in 44.6% of patients without ILD. This evidence concerns the gene BTG3 and interstitial lung disease.